
Company valuation, historical trends, and peer comparisons.
According to Sight Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 484.22M. This represents a change of 111.44% compared to the average of 229.01M of the last 4 quarters.
The mean historical Enterprise Value of Sight Sciences, Inc. over the last ten years is 677.63M. The current 484.22M Enterprise Value has changed -28.54% with respect to the historical average. Over the past ten years (40 quarters), SGHT's Enterprise Value was at its highest in in the June 2021 quarter at 1.41B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
677.63M
Median
521.20M
Minimum
102.49M
Maximum
1.54B
Discovering the peaks and valleys of Sight Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 253.53%
Maximum Annual Enterprise Value = 1.54B
Minimum Annual Increase = -65.87%
Minimum Annual Enterprise Value = 102.49M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 362.35M | 253.53% |
| 2024 | 102.49M | -30.85% |
| 2023 | 148.21M | -65.87% |
| 2022 | 434.22M | -28.60% |
| 2021 | 608.18M | -60.45% |
| 2020 | 1.54B | 37.39% |
| 2019 | 1.12B | 0.95% |
The current Enterprise Value of Sight Sciences, Inc. (SGHT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
204.35M
5-year avg
331.09M
10-year avg
677.63M
Sight Sciences, Inc.’s Enterprise Value is less than Glaukos Corporation (14.18B), less than Alcon Inc. (39.49B), greater than IRIDEX Corporation (12.21M), less than Harrow Health, Inc. (1.27B), less than Ocular Therapeutix, Inc. (987.31M), less than Bausch Health Companies Inc. (21.31B), less than SpyGlass Pharma, Inc. Common Stock (858.52M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 14.18B | $14.24B | |
| 39.49B | $35.55B | |
| 12.21M | $12.88M | |
| 1.27B | $1.05B | |
| 987.31M | $1.51B | |
| 21.31B | $3.08B | |
| 858.52M | $1.08B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sight Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sight Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sight Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Sight Sciences, Inc. (SGHT)?
What is the 3-year average Enterprise Value for Sight Sciences, Inc. (SGHT)?
What is the 5-year average Enterprise Value for Sight Sciences, Inc. (SGHT)?
How does the current Enterprise Value for Sight Sciences, Inc. (SGHT) compare to its historical average?